Trial intelligence / Profile preview

Alternative ribavirin dosing versus standard dosing with Pegasys in treatment-naive genotype 1 chronic hepatitis C

2010-018332-41Phase 4Completed

Sponsor

Dept. of Infectious diseases / virology University of Gothenburg

Start

Apr 2010

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules

Countries

1